PMID- 21092675 OWN - NLM STAT- MEDLINE DCOM- 20111027 LR - 20101124 IS - 1673-0860 (Print) IS - 1673-0860 (Linking) VI - 45 IP - 9 DP - 2010 Sep TI - [Expression and clinical significance of CCR6, CCR7 and CD4(+)CD25(+) Foxp3(+) regulatory T cells in laryngeal squamous cell carcinoma and neck lymphatic metastasis]. PG - 759-64 AB - OBJECTIVE: To evaluate the expressions and clinical significance of chemokine receptor 6 (CCR6), chemokine receptor 7(CCR7) and CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) in laryngeal squamous cell carcinoma (LSCC) and metastatic lymph nodes. METHODS: Blood samples and fresh specimens of LSCC were obtained from 50 LSCC patients treated. Blood samples from normal subjects were donated by 20 volunteers. The mRNA expressions of CCR6, CCR7 and their ligands CCL20, CCL19/CCL21 were detected by real-time quantitative RT-PCR. Expressions of CCR6 and CCR7 proteins were examined with immunohistochemistry. Flow cytometry was used to investigate Treg in peripheral blood mononuclear cells. RESULTS: The relative expression levels of CCR6, CCR7 and CCL19 mRNA in tumor tissues with lymphatic metastases were significantly lower than those without lymph node metastases (P < 0.05), while the relative expression level of CCL20 mRNA in tumor tissues with lymphatic metastases was significantly higher than that of those without metastatic lymph nodes (t = 2.39, P < 0.05). Immunohistochemistry showed that the expression levels of CCR6 and CCR7 in tumor tissues in patients with lymph node metastases than those without lymph node metastases. CCR6 and CCR7 expressions were also detected in metastatic lymph nodes. Flow cytometry showed that the percentage of Treg in blood in LSCC patients was significantly higher than that in normal subjects (t = 2.19, P < 0.05), and those with lymph node metastasis had a much higher percentage of Treg (t = 2.14, P < 0.05). CONCLUSIONS: CCR6, CCR7 and Treg could take part in the process of lymph node metastasis in LSCC patients. FAU - Chen, Bin AU - Chen B AD - Department of Otolaryngology, Eye Ear Nose & Throat Hospital of Fudan University, Shanghai 200031, China. FAU - Lu, Li-ming AU - Lu LM FAU - Tao, Lei AU - Tao L FAU - Zhou, Liang AU - Zhou L FAU - Li, Shi-min AU - Li SM FAU - Zhu, Li AU - Zhu L LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi JT - Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery JID - 101247574 RN - 0 (CCR6 protein, human) RN - 0 (CCR7 protein, human) RN - 0 (FOXP3 protein, human) RN - 0 (Forkhead Transcription Factors) RN - 0 (Interleukin-2 Receptor alpha Subunit) RN - 0 (Receptors, CCR6) RN - 0 (Receptors, CCR7) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Carcinoma, Squamous Cell/*immunology/metabolism/pathology MH - Female MH - Flow Cytometry MH - Forkhead Transcription Factors/metabolism MH - Humans MH - Interleukin-2 Receptor alpha Subunit/metabolism MH - Laryngeal Neoplasms/*immunology/metabolism/pathology MH - Lymphatic Metastasis MH - Male MH - Middle Aged MH - Receptors, CCR6/*metabolism MH - Receptors, CCR7/*metabolism MH - T-Lymphocytes, Regulatory/*immunology/metabolism EDAT- 2010/11/26 06:00 MHDA- 2011/10/28 06:00 CRDT- 2010/11/25 06:00 PHST- 2010/11/25 06:00 [entrez] PHST- 2010/11/26 06:00 [pubmed] PHST- 2011/10/28 06:00 [medline] PST - ppublish SO - Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Sep;45(9):759-64.